Chemiluminescence responses and chemotaxis of monocytes from patients with early rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 25, Issue 2, 1996, Pages 92-96

  Repo, H ^a   Paimela, L ^b   Leirisalo Repo, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chemiluminescence; Chemotaxis; Monocyte; Rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; PARACETAMOL; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0029985894     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609069214     Document Type: Article

References (37)

1. Pincus T. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988; 41: 1037-41.
2. Paimela L, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 1991; 34: 815-21.
3. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-89.
4. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
5. Ratcliffe A, Tyler JA, Hardingham TE. Articular cartilage cultured with interleukin 1. Increased release of link protein, hyaluronate-binding region and other proteoglycan fragments. Biochem J 1986; 238: 571-80.
6. Saklatvala J. TNFalpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322: 547-9.
7. Thomson BM, Mundy GR, Chambers TJ. Tumour necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987; 138: 775-9.
8. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-B in rheumatoid arthritis. J Clin Invest 1991; 87: 463-9.
9. Paimela L, Johansson-Stephansson EA, Koskimies S, Leirisalo-Rep M. Depressed cellular immunity in early rheumatoid arthritis. Clin Exp Rheumatol 1990; 8: 433-7.
10. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992; 51: 743-6.
11. Leirisalo-Repo M, Paimela L, Koskimies S, Repo H. Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation 1993; 17: 427-42.
12. Paimela L, Leirisalo-Repo M, Helve T, Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993; 22: 220-4.
13. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175-6.
14. Repo H, Saxen L, Jäättelä M, Ristola M, Leirisalo-Repo M. Phagocyte function in juvenile periodontitis. Infect Immun 1990; 58: 1085-92.
15. Koivuranta-Vaara P, Leirisalo-Repo M, Repo H. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis 1987; 46: 307-13.
16. Harth M, Keown PA, Orange JF. Monocyte dependent excited oxygen radical generation in rheumatoid arthritis: Inhibition by gold sodium thiomalate. J Rheumatol 1983; 10: 701-7.
17. Hurst NP, Bessac B, Nuki G. Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis 1984; 43: 28-33.
18. Bell AL, Hurst NP, Nuki G. Effect of corticosteroid therapy on blood monocyte superoxide generation in rheumatoid arthritis: studies in vitro and ex vivo. Br J Rheumatol 1986; 25: 366-71.
19. Fujii I, Shingu M, Nobunaga M. Monocyte activation in early onset rheumatoid arthritis. Ann Rheum Dis 1990; 49: 497-503.
20. Szefler SJ, Norton CE, Ball B, Gross JM, Aida Y, Pabst MJ. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming. J Immunol 1989; 142: 3985-92.
21. Jendrossek V, Buth S, Stetter C, Gahr M. Modulation of human monocyte superoxide production by recombinant interleukin-3. Agents Actions 1992; 37: 127-33.
22. Chu E, Casey LC, Harris JE, Braun DP. Suppression of the development of tumoricidal function in gamma interferon-treated human peripheral blood monocytes by lipopolysaccharide: The role of cyclooxygenase metabolites. J Clin Immunol 1993; 13: 49-57.
23. Barrera P, Boerbooms AMT, Demacker PNM, van de Putte LBA, Gallati H, van der Meer JWM. Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate. Br J Rheumatol 1994; 33: 1017-24.
24. Leirisalo-Repo M, Paimela L, Jäättelä M, Koskimies S, Repo H. Production of TNF by monocytes of patients with early rheumatoid arthritis is increased. Scand J Rheumatol (in press).
25. Mazure G, Jayawardene SA, Perry JD, McCarthy D, Macey MG, Dumonde DC, Brown KA. Abnormal binding properties of blood monocytes in rheumatoid arthritis. Agents Actions 1993; 38: C41-3.
26. Sadouk M, Vaquero C, de la Tour B, Amor B, Toubert A. Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients. Clin Immunol Immunopathol 1990; 56: 37-45.
27. MacKinnon SK, Starkebaum G. Monocyte Fc receptor function in rheumatoid arthritis. Enhanced cell-binding of IgG induced by rheumatoid factors. Arthritis Rheum 1987; 30: 498-506.
28. Dechatelet LR, Long GD, Shirley PS, Bass DA, Thomas MJ, Henderson FW, et al. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol 1982; 129: 1589-93.
29. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods 1987; 97: 209-13.
30. Jiménez López A, Olmos Martínez JM, Garcia Palomo JD, De Dios Martin B, Pedraz Garcia MJ, Lorente Toledano F. Monocyte functional defects in rheumatoid arthritis. Allergol Immunopathol 1982; 10: 353-9.
31. Katona IM, Ohura K, Allen JB, Wahl LM, Chenoweth DE, Wahl SM. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators. J Immunol 1991; 146: 708-14.
32. Simmons KM, Brown KA, Kirk AP, Perry JD, Dumonde DC. Enhanced chemotaxis of monocytes in rheumatoid arthritis. Br J Rheumatol 1987; 26: 245-50.
33. Al-Sumidaie AM, Jones DL, Young HL. Characterization of the under-agarose method for quantifying migration of highly punned human monocytes. J Immunol Methods 1984; 75: 129-40.
34. Repo H, Jokipii AMM, Leirisalo M, Kosunen TU. Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis. Clin Exp Immunol 1980; 40: 620-6.
35. Wolfe F, Hawley DJ. Remission in rheumatoid arthritis. J Rheumatol 1985; 12: 245-52.
36. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis of rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979; 66: 377-84.
37. Scheinberg MA, Santos LMB, Finkelstein AE. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes. J Rheumatol 1982; 9: 366-9.